Corbus Pharmaceuticals Holdings Inc. Stock Rallies 5.5%, Outperforms Peers
Dow Jones2026/08/21 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. rallied 5.5% to $10.38 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.4% to 26,180.45 and the Dow Jones Industrial Average rising 1.0% to 53,277.01.
The stock's rise snapped a three-day losing streak.
Corbus Pharmaceuticals Holdings Inc. closed 49.5% below its 52-week high of $20.56, which the company achieved on October 20th.
The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. fell 1.9% to $5.28, Fortress Biotech Inc. rose 3.6% to $2.87, and Viking Therapeutics Inc. fell 1.37% to $33.89.
Trading volume totaled 603,376, compared to the 50-day average of 385,956.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 21, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Euro drifts toward the bottom of its range as US rate bets climb
Investors reportedly offering Anthropic allocation shares at premiums of up to 5% ahead of its IPO
According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.
Crypto prices
More
